Remi Meyrueix

This inventor holds 17 USPTO granted patents and 1 published patent application, plus 8 CIPO patents and 1 EPO patent. Top assignees: Flamel Technologies, Rhone-Poulenc Chimie, Flamel Ireland Limited. Active years: 1991-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Remi Meyrueix. Retrieved from https://idiyas.com/inventor/remi-meyrueix

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 1)

% Patents Active = 82.4

CIPO Patents = 8 (Patent Applications = 7)

EPO Patents = 1

Average Co-Inventor Count = 3.5

ph-index = 10

Forward Citations = 280(Granted Patents)

Location History:

Lyon, FR (1991)
Le Bois Saint-Rambert, FR (2014)
Lyons, FR (1991 - 2018)

Company Filing History:

Flamel Ireland Limited

Years Active: 1991-2018

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE47084 - Oral medicinal product with modified release of at least one active principle in multimicrocapsular form (2018-10-15),

2. 8734850 - Oral medicinal product with modified release of at least one active principle in multimicrocapsular form (2014-05-27),

3. 8236353 - Self-precipitating pharmaceutical formulations for the modified release of an active principle (2012-08-07),

4. 8197850 - Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same (2012-06-12),

5. 6790438 - Cross-linked collagenic peptide for preventing post-surgical adhesions (2004-09-14),

6. 6180141 - Composite gel microparticles as active principle carriers (2001-01-30),

7. 6133199 - Process and compositions promoting biological effectiveness of exogenous (2000-10-17),

8. 6001958 - Crosslinkable polymer, particularly for optical and non-linear optical (1999-12-14),

9. 5811507 - Polyesterimides for use in linear and/or non-linear optics, and one (1998-09-22),

10. 5535048 - Nonlinearly optically active compounds (1996-07-09),

11. 5444136 - Optionally oriented, monomeric and polymeric nonlinearly optically (1995-08-22),

12. 5359072 - Nonlinearly optically active compounds (1994-10-25),

13. 5324827 - Optionally oriented, monomeric and polymeric nonlinearly optically (1994-06-28),

14. 5189134 - Nonlinearly optically active polymers (1993-02-23),

15. 5156774 - Thiophene-related compounds active in nonlinear optics, materials and (1992-10-20),

Title: Remi Meyrueix: Innovator in Oral Pharmaceutical Products

Introduction

Remi Meyrueix is a distinguished inventor based in Lyon, France, known for her contributions to the pharmaceutical industry. With an impressive portfolio of 17 patents, she has made significant strides in developing oral medicinal products that enhance therapeutic efficacy.

Latest Patents

Among her notable inventions is an oral medicinal product with modified release of at least one active principle in multimicrocapsular form. This innovation is particularly relevant in the field of oral pharmaceutical products, emphasizing a design that allows for controlled release of active principles through a dual mechanism of 'time triggering' and 'pH triggering'. The invention involves microcapsules that contain a core with the active principle and various swelling agents. These capsules are coated to ensure the modified release of the active ingredient over time, improving administration regulations and therapeutic benefits.

Career Highlights

Throughout her career, Remi has been associated with several prominent companies, including Flamel Technologies and Rhône-Poulenc Chimie. Her work in these organizations has allowed her to develop and refine her inventions, contributing to advancements in pharmaceutical technologies.

Collaborations

During her journey as an inventor, Remi has collaborated with esteemed colleagues, including Gerard Mignani and Gerard Soula. These partnerships have fostered an environment of innovation and shared expertise, enabling significant breakthroughs in the oral pharmaceutical domain.

Conclusion

Remi Meyrueix continues to contribute to the field of pharmaceuticals with her innovative spirit and dedication to enhancing oral medicinal products. Her work exemplifies the impact of creativity and research in shaping the future of healthcare solutions.

Profile summary based on public USPTO records.